Read by QxMD
Medicina
Gratis
'Read by QxMD' provides a single place to keep up with new medical & scientific research, read outstanding topic reviews and search PubMed.
This iPhone & iPad app provides a simple interface that drives discovery and seamless access to the medical literature by reformatting it into a personalized digital journal.
Praise for Read:
5 stars: "Stellar. The future of medical literature review... This could be the best application to stay up-to-date in medicine since, well, UpToDate." - User Review
4¾ stars: "The Flipboard for medical journals has arrived" and among "...the most innovative medical apps"
- iMedicalApps.com
On Apple's 'What's Hot' list in >60 countries, as well as Medical Essentials & Apps for Healthcare Professionals. Featured in Apple iBook: "iOS in Healthcare: Revolutionizing Healthcare Productivity"
Features:
- Get full text PDFs with one tap
- Keep up with the latest new research that will impact your practice
- Browse through 1000s of outstanding topic reviews
- Search millions of articles from PubMed and our database of outstanding topic reviews
- Read your favorite journals or browse article collections.
- Access full text through your university/institutional subscription or via open access publishers
- Share articles with colleagues over email, Twitter and Facebook
- Organize and review your personal collection of articles
Why did we build 'Read by QxMD'?
Health care professionals need to stay up to date on the latest medical research and topic reviews to provide optimal care. Unfortunately, the process of content discovery is broken with research artificially compartmentalized by publishers and hidden behind countless institutional pay walls.
At QxMD, we believe that knowledge translation– the process by which new knowledge is incorporated into clinical practice – is an important and unsolved challenge for our health care system. We hope that ‘Read by QxMD’ will be a part of the solution.
Seamless 1-tap access available at thousands of institutions.
Sources:
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Founded by medical professionals, QxMD is dedicated to creating high quality point-of-care tools for practicing health care professionals.
Various Bug Fixes
El desarrollador, WebMD, ha indicado que las prácticas de privacidad de la app pueden incluir la gestión de datos descrita a continuación. Para obtener más información, consulta la política de privacidad del desarrollador .
Datos usados para rastrearte
Los siguientes datos pueden usarse para rastrearte en apps y sitios web propiedad de otras empresas:
- Datos de contacto
- Identificadores
- Datos de uso
Datos vinculados contigo
Los siguientes datos pueden recopilarse y vincularse con tu identidad:
- Datos de contacto
- Contenido del usuario
- Historial de búsqueda
- Identificadores
- Datos de uso
Datos no vinculados contigo
Los siguientes datos pueden recopilarse, pero no se vinculan con tu identidad:
- Diagnósticos
Accesibilidad
El desarrollador no ha indicado todavía las prestaciones de accesibilidad que son compatibles con la app. Más información
Ficha técnica
- Tamaño
- 183,4 MB
- Categoría
- Medicina
- Compatibilidad
Requiere iOS 16.6 o posterior.
- iPhone
Requiere iOS 16.6 o posterior. - iPad
Requiere iPadOS 16.6 o posterior. - Apple Vision
Requiere visionOS 1.0 o posterior.
- Idiomas
Español y 5 más
- Español, Alemán, Francés, Inglés, Italiano, Portugués
- Edad
16+
- 16+
- Frecuente
Información sobre tratamientos médicos
Contiene
Publicidad
Temas de salud o bienestar
- Proveedor
WebMD Health Corporation
- WebMD Health Corporation se ha identificado como comerciante de esta app y ha confirmado que este producto o servicio cumple la legislación de la Unión Europea.
- Número DUNS
602670742 - Dirección
283-299 MARKET ST 2
GATEWAY CENTER
NEWARK New Jersey 07102
Estados Unidos - Número de teléfono
+1 3102804241 - Correo electrónico
medscapemobile@webmd.net
- Derechos de autor
- © 2025 QxMD Software Inc.